Blog

New regulatory roadmap defines 161 priority themes for medical devices, pharmaceuticals, and health products  Key Highlights  The Brazilian Health Regulatory...

Anvisa, the National Health Surveillance Agency, is the body responsible for regulating, authorizing, and supervising the entry and commercialization of...

In the healthcare sector, regulation and innovation are not opposing forces, they are complementary. When well-structured, regulation becomes the foundation...

The medical device sector in Brazil faces a scenario of high relevance and natural vocation. There are structural, demographic, and...

The Brazilian medical device market is one of the most complex and promising in the world. With a population of...

In the fast-evolving world of medical devices, efficiency is the bridge that connects innovation to patient care. Every technological advancement...

The global medical device market is undergoing a profound transformation. As new technologies emerge at unprecedented speed  combined with increasingly complex regulatory requirements and healthcare access demands companies must...

Regulatory Framework Change: Companies Have Until May 30, 2026 to Transition  Executive Summary  In a significant regulatory development, ANVISA (Brazilian...

Brazil is consolidating its position as one of the most promising markets for international medical device manufacturers. With an increasingly...